Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
8.
Health Sci Rep ; 5(1): e491, 2022 Jan.
Article in English | MEDLINE | ID: mdl-35229047
9.
Head Neck ; 39(3): 578-594, 2017 03.
Article in English | MEDLINE | ID: mdl-27882625

ABSTRACT

Cutaneous squamous cell carcinoma (SCC) is a malignancy that arises from epidermal keratinocytes. Although the majority of cutaneous SCC cases are easily treated without further complication, some behave more aggressively and carry a poor prognosis. These "high-risk" cutaneous SCCs commonly originate in the head and neck and have an increased tendency toward recurrence, local invasion, and distant metastasis. Factors for high-risk cutaneous SCC include large size (>2 cm), a deeply invasive lesion (>2 mm), incomplete excision, high-grade/desmoplastic lesions, perineural invasion (PNI), lymphovascular invasion, immunosuppression, and high-risk anatomic locations. Both the National Comprehensive Cancer Network® (NCCN® ) and the American Joint Committee on Cancer (AJCC) identify several of these high-risk features of cutaneous SCC. The purpose of this article was to review the high-risk features included in these guidelines, as well as their notable discrepancies and omissions. We also provide a brief overview of current prophylactic measures, surgical options, and adjuvant therapies for high-risk cutaneous SCC. © 2016 Wiley Periodicals, Inc. Head Neck 39: 578-594, 2017.


Subject(s)
Carcinoma, Squamous Cell/pathology , Medical Oncology/standards , Practice Guidelines as Topic , Skin Neoplasms/pathology , Biopsy, Needle , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/therapy , Combined Modality Therapy , Disease-Free Survival , Female , Humans , Immunohistochemistry , Male , Neoplasm Invasiveness/pathology , Neoplasm Staging , Prognosis , Risk Assessment , Skin Neoplasms/mortality , Skin Neoplasms/therapy , Societies, Medical , Survival Analysis , Treatment Outcome , United States
SELECTION OF CITATIONS
SEARCH DETAIL